ReviewPoultry science2026
Modulation of the intestinal microbiota: impact on productive performance and intestinal health in broiler breeder hens.
Review in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the effects of different administration protocols of an undefined microbial culture (Normal Avian Gut Flora - NAGF) on production performance metrics, intestinal health, and cecal microbiota composition in Cobb 500 broiler breeder hens during the early production phase (24 to 32 weeks of age). A total of 48,000 broiler breeder hens were allocated across four commercial units, including an unsupplemented control group and three treatment groups receiving NAGF via drinking water at different application frequencies: weekly (Group 1), biweekly (Group 2), and every 21 days (Group 3). Flock performance metrics (egg production and mortality) and macroscopic clinical health scores were analyzed using Generalized Linear Mixed Models (GLMM) for longitudinal repeated measures. Cecal microbiota composition was evaluated at 32 weeks from 20 biological sample pools (n=5 pools/group, derived from 100 hens) via 16S rRNA gene amplicon sequencing. To distinguish statistical significance from practical relevance in this large-scale field trial, biological response magnitudes were prioritized using effect size estimators [Exp(B)]. Administration protocols significantly influenced flock survival and lay performance. The biweekly protocol (Group 2) provided optimal protective efficiency, exhibiting a lower estimated mortality rate than the Control group [Exp(B)=0.753; P=0.012] and superior laying persistence relative to controls. Conversely, extending the administration window to 21 days (Group 3) was counterproductive, resulting in a higher estimated mortality rate [Exp(B)=1.258; P=0.042]. Treated groups exhibited numerical reductions in intestinal gas accumulation and macroscopic lesion scores, although the overall differences were not statistically significant (P > 0.05). Differential abundance analysis using ANCOM-BC confirmed targeted taxonomic shifts, particularly the depletion of potential opportunistic lineages such as Massilistercora and taxa within the order Clostridiales. Collectively, these findings demonstrate that NAGF efficacy is strictly frequency-dependent: biweekly administration optimizes intestinal integrity and flock survival, whereas an extended 21-day interval proves ineffective and should be avoided in commercial health management programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.